--- title: "The concept of innovative drugs fluctuates and rebounds, JZT hits the limit up" type: "News" locale: "en" url: "https://longbridge.com/en/news/252955164.md" description: "The concept of innovative drugs has rebounded, with JZT hitting the daily limit, Hinova, RemeGen, and Shenzhou Cell rising over 10%, while Fuyuan Pharmaceutical, Kangchen Pharmaceutical, Guangshengtang, and Nuo Cheng Jianhua are among the top gainers" datetime: "2025-08-14T02:56:10.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/252955164.md) - [en](https://longbridge.com/en/news/252955164.md) - [zh-HK](https://longbridge.com/zh-HK/news/252955164.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/252955164.md) | [繁體中文](https://longbridge.com/zh-HK/news/252955164.md) # The concept of innovative drugs fluctuates and rebounds, JZT hits the limit up The innovative drug concept has rebounded, with JZT hitting the daily limit, Hinova, RemeGen, and Shenzhou Cell rising over 10%, while Fuyuan Pharmaceutical, Kangchen Pharmaceutical, Guangshengtang, and Nuo Cheng Jianhua are among the top gainers ### Related Stocks - [JZT (000989.CN)](https://longbridge.com/en/quote/000989.CN.md) - [Hinova (688302.CN)](https://longbridge.com/en/quote/688302.CN.md) - [RemeGen (688331.CN)](https://longbridge.com/en/quote/688331.CN.md) - [REMEGEN (09995.HK)](https://longbridge.com/en/quote/09995.HK.md) ## Related News & Research - [Gan & Lee Pharmaceuticals Gets Regulatory Nod for Prostate Cancer Drug Trials](https://longbridge.com/en/news/277599001.md) - [Hong Kong-listed Chinese drug firms set to turn corner on rising sales, deals](https://longbridge.com/en/news/277340041.md) - [Cosco Shipping Energy Transportation responds to unusual share price moves](https://longbridge.com/en/news/277596582.md) - [Gushengtang to Acquire Majority Stake in Three Chinese Medical Institutions](https://longbridge.com/en/news/277715836.md) - [SSY Group's Respiratory Drug Approved for Production in China](https://longbridge.com/en/news/277561555.md)